# Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)

> **NCT00598611** · PHASE3 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 29 (actual)

## Conditions studied

- Chronic Urticaria

## Interventions

- **DRUG:** desloratadine
- **DRUG:** desloratadine

## Key facts

- **NCT ID:** NCT00598611
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2012-05-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598611

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598611, "Effects of 5 mg vs. 20 mg Desloratadine on Skin Lesions in Patients With Chronic Urticaria (CU)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00598611. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*